CLINICAL STUDIES

Ironwood CKD Study

A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety and Efficacy of IW-1973 in Patients with Type 2 Diabetes with Albuminuria Treated with Renin-Angiotensin System Inhibitors

Study Phase:

Phase 2

Criteria:

  • Male or Female 25 to 75 years of age
  • History of CKD
  • History of Hypertension
Register